arrow
T

Thomas Foltynie

UCL Institute of Neurology
H指数:98
被引数:3.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Timing of Deep Brain Stimulation and Cognitive Trajectories in GBA1-Associated Parkinson's Disease

GBA1相关帕金森病中深脑刺激的时机与认知轨迹

2026-10-010
OAAI
The patient centric development of an inclusive multi-arm multi-stage trial for Parkinson disease

针对帕金森病的以患者为中心的包容性多臂多阶段试验开发

2026-09-220
OAAI
Observations on an Open-Label Phase 1/2 Dopamine Gene Therapy Trial (OXB-102/Axo-Lenti-PD) in People with Parkinson's Disease

关于帕金森病患者开放标签I/II期多巴胺基因疗法试验(OXB-102/Axo-Lenti-PD)的观察

2026-05-280
OAAI
Clinical prognostic indicators in multiple system atrophy

多系统萎缩的临床预后指标

Brain
IF11.7
2026-05-070
OA
Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathies

α-突触核蛋白种子在脑脊液中的定量测量有助于诊断synucleinopathies

2025-10-030
OA
Depressive symptoms can negatively influence patient reported disease severity after subthalamic nucleus stimulation for Parkinson's disease

抑郁症状可能会对帕金森病患者接受下丘脑 nucleus 刺激后的自报疾病严重程度产生负面影响。

2025-06-260
OA
Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study

α-突触核蛋白种子扩增试验动力学指标在帕金森病中的诊断和预后价值:一项纵向队列研究

2025-06-180
OA
The TransEuro open-label trial of human fetal ventral mesencephalic transplantation in patients with moderate Parkinson's disease

TransEuro开放标签试验:人类胎儿腹侧中脑移植治疗中度帕金森病患者的临床研究

2025-05-020
OA
Improving recruitment and retention of people with Parkinson's disease to clinical studies: A scoping review
2025-01-140
OA
Genome-wide determinants of mortality and motor progression in Parkinson's disease

帕金森病死亡率和运动进展的全基因组决定因素

2024-06-070
OAAI
Polygenic Risk Scores Validated in Patient-Derived Cells Stratify for Mitochondrial Subtypes of Parkinson's Disease

在帕金森氏病线粒体亚型的患者衍生细胞中验证的多基因风险评分

2024-05-201
OA